342 related articles for article (PubMed ID: 27320287)
1. Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
Pivovarova O; Höhn A; Grune T; Pfeiffer AF; Rudovich N
Ann Med; 2016 Dec; 48(8):614-624. PubMed ID: 27320287
[TBL] [Abstract][Full Text] [Related]
2. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
Tang WJ
Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
[TBL] [Abstract][Full Text] [Related]
3. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
Qiu WQ; Folstein MF
Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus.
Haque R; Nazir A
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):259-64. PubMed ID: 24059320
[TBL] [Abstract][Full Text] [Related]
5. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
[TBL] [Abstract][Full Text] [Related]
6. New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs.
Martín-Martín Y; Pérez-García A; Torrecilla-Parra M; Fernández-de Frutos M; Pardo-Marqués V; Casarejos MJ; Busto R; Ramírez CM
Cells; 2022 Aug; 11(16):. PubMed ID: 36010613
[TBL] [Abstract][Full Text] [Related]
7. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
8. Targeting Insulin-Degrading Enzyme in Insulin Clearance.
Leissring MA; González-Casimiro CM; Merino B; Suire CN; Perdomo G
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668109
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
10. Modulation of insulin degrading enzyme activity and liver cell proliferation.
Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
[TBL] [Abstract][Full Text] [Related]
11. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review.
Azam MS; Wahiduzzaman M; Reyad-Ul-Ferdous M; Islam MN; Roy M
Pharm Res; 2022 Apr; 39(4):611-629. PubMed ID: 35378698
[TBL] [Abstract][Full Text] [Related]
13. Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice.
Deprez-Poulain R; Hennuyer N; Bosc D; Liang WG; Enée E; Marechal X; Charton J; Totobenazara J; Berte G; Jahklal J; Verdelet T; Dumont J; Dassonneville S; Woitrain E; Gauriot M; Paquet C; Duplan I; Hermant P; Cantrelle FX; Sevin E; Culot M; Landry V; Herledan A; Piveteau C; Lippens G; Leroux F; Tang WJ; van Endert P; Staels B; Deprez B
Nat Commun; 2015 Sep; 6():8250. PubMed ID: 26394692
[TBL] [Abstract][Full Text] [Related]
14. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.
Zhang H; Liu D; Huang H; Zhao Y; Zhou H
Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus.
Ohyagi Y; Miyoshi K; Nakamura N
Adv Exp Med Biol; 2019; 1128():227-248. PubMed ID: 31062332
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: Implications for Alzheimer's disease.
Haque R; Nazir A
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2454-2462. PubMed ID: 27443962
[TBL] [Abstract][Full Text] [Related]
18. Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
Tundo GR; Sbardella D; Ciaccio C; Grasso G; Gioia M; Coletta A; Polticelli F; Di Pierro D; Milardi D; Van Endert P; Marini S; Coletta M
Crit Rev Biochem Mol Biol; 2017 Oct; 52(5):554-582. PubMed ID: 28635330
[TBL] [Abstract][Full Text] [Related]
19. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
[TBL] [Abstract][Full Text] [Related]
20. Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.
Ivancic VA; Krasinski CA; Zheng Q; Meservier RJ; Spratt DE; Lazo ND
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
